Oral cancer- monoclonal antibodies combined with standard treatment may improve outcomes

shutterstock_54791728 - Cancer word cloud

12 trials were included in this Cochrane review of molecularly targeted therapies and immunotherapies as adjuncts to standard treatments for oral cancer. Moderate evidence was found that standard therapy plus epidermal growth factor receptor monoclonal antibody (EGFR mAb) reduced mortality and locoregional failures.

[read the full story...]